Vistagen therapeutics qtrly loss per share $0.13

Vistagen therapeutics reports fiscal 2020 second quarter financial results and provides pipeline overview.vistagen therapeutics inc - at september 30, 2019, vistagen had cash and cash equivalents of $4.1 million.vistagen therapeutics inc - qtrly loss per share $0.13.
VTGN Ratings Summary
VTGN Quant Ranking